Diagnosing Value and Connecting the Dots…

Today, clinical commercialization efforts are increasingly fragmented - leading to unacceptable economic consequences.

  • We define value for multiple market access stakeholders, including: Health Systems, Health Plans, Self Insured Employers, Physicians and Patients. That value can be translated into clinical, economic, quality of life and patient satisfaction metrics.

  • We work collaboratively to develop customized value pathways.

  • DiagnoEconomics, Inc. can help your organization bridge the gaps between commercialization, Health Economics Outcomes Research (HEOR) and Market Access by implementing the value pathway to drive pilot studies, publications and evidence based contracting opportunities.

  • We partner with your entire organization to drive success, from concept to contract; connecting the dots!

Partnering with DxEcon will uncover your full value proposition across market access stakeholders to increase your bottom line.



Our Services

Throughout each stage of an engagement, from the assessment of opportunities to navigating with your team, we make the connections between commercialization, HEOR and Market Access efforts.

Our goal is to shorten the time to patient access while reshaping the revenue ‘S-curve’ for economic growth.

We focus on customized, evidence-based market access pathways, value-driven, employer-based reimbursement, medical policy implementation, contracting and partnering opportunities that may align with or bypass traditional health plan market access routes.



Our combined knowledge, experience and depth of peer reviewed evidence give us true industry insight. 




Start the conversation with DiagnoEconomics

Fill out a form - we'd love to talk to you!

Name *

Question: Where did the name "DiagnoEconomics" come from?

Answer: It's a Portmanteau:

port·man·teau  / pôrt’mantō /noun

A word blending the sounds and combining the meanings of two others,

for example motel (from ‘motor’ and ‘hotel’) or brunch (from breakfast and ‘lunch’).

Pharmaceutical + Economics = PharmacoEconomics

Diagnostic + Economics = DiagnoEconomics